Juan Gonzalez-Abraldes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Juan Gonzalez-Abraldes has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Jaime Bosch
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain
5 shared publications- Jackie Bosch
Population Health Research Institute, Hamilton Health Sciences and McMaster University , 237 Barton Street East, Hamilton, Ontario L8L 2X2
3 shared publications Angels Escorsell
2 shared publicationsEduardo Moitinho
2 shared publications- Juan Carlos García-Pagán
Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut de Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
2 shared publications Monica González
Department of Gastroenterology, Hospital Universitario Ramón y Cajal, University of Alcalá, Madrid, Spain
2 shared publications
Latest Publications
- 1 October 2012
- Published by Elsevier in Gastroenterología y Hepatología
- Vol. 35 (8) , 533-534
Asignación de factor de impacto a la revista Gastroenterología y Hepatología
- 1 October 2012
- Published by Elsevier in Gastroenterología y Hepatología
- Vol. 35 (8) , 533-534
Asignación de factor de impacto a la revista Gastroenterología y Hepatología
- 9 September 2009
- Published by Wiley in Liver International
- Vol. 30 (7) , 995
An uncommon cause of massive scrotal enlargement
- 9 September 2009
- Published by Wiley in Liver International
- Vol. 30 (7) , 995
An uncommon cause of massive scrotal enlargement
- 1 December 2008
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 6 (12) , 1412-1417
Portal Hypertension–Related Complications After Acute Portal Vein Thrombosis: Impact of Early Anticoagulation
- 1 December 2008
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 6 (12) , 1412-1417
Portal Hypertension–Related Complications After Acute Portal Vein Thrombosis: Impact of Early Anticoagulation
- 1 February 2008
- Published by Georg Thieme Verlag KG in Seminars in Liver Disease
- Vol. 28 (1) , 003-025
Portal Hypertension and Gastrointestinal Bleeding
Variceal bleeding is one of the most serious complications of portal hypertension. The driving force for the development of varices is an increase in portal pressure. As portal hypertension progresses, varices dilate until they finally rupture and bleed. This sequence of events might be prevented by achieving a sufficient decrease in portal pressure or by acting locally at the varices with endoscopic treatments. This article reviews the rationale for the management of portal hypertension and the current recommendations for the prevention and treatment of variceal bleeding.
- 1 February 2008
- Published by Georg Thieme Verlag KG in Seminars in Liver Disease
- Vol. 28 (1) , 003-025
Portal Hypertension and Gastrointestinal Bleeding
Variceal bleeding is one of the most serious complications of portal hypertension. The driving force for the development of varices is an increase in portal pressure. As portal hypertension progresses, varices dilate until they finally rupture and bleed. This sequence of events might be prevented by achieving a sufficient decrease in portal pressure or by acting locally at the varices with endoscopic treatments. This article reviews the rationale for the management of portal hypertension and the current recommendations for the prevention and treatment of variceal bleeding.
- 1 November 2005
- Published by Elsevier in Clinics in Liver Disease
- Vol. 9 (4) , 685-713
The Management of Portal Hypertension
- 1 November 2005
- Published by Elsevier in Clinics in Liver Disease
- Vol. 9 (4) , 685-713
The Management of Portal Hypertension
- 1 April 2005
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 39 (4) , S125-S130
Portal Hypertension
The initial factor leading to portal hypertension is an increase in hepatic resistance. Later, an increase in portal blood flow contributes to maintain and exacerbate portal hypertension despite the development of portosystemic collaterals. The critical step in the development and acceptance of these concepts, which proved crucial for the management of patients with portal hypertension, was the development of animal models. These allowed the full characterization of the profound hemodynamic abnormalities in the systemic and splanchnic circulation associated with portal hypertension, and the elucidation of the molecular mechanisms implicated in these disturbances. This review traces how seminal clinical observations in the 1950s raised meaningful questions that were subsequently answered at the bench, leading to our current understanding of the pathophysiology of portal hypertension and of the pathogenesis of severe complications of cirrhosis, such as variceal bleeding or ascites.
- 1 April 2005
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 39 (4) , S125-S130
Portal Hypertension
The initial factor leading to portal hypertension is an increase in hepatic resistance. Later, an increase in portal blood flow contributes to maintain and exacerbate portal hypertension despite the development of portosystemic collaterals. The critical step in the development and acceptance of these concepts, which proved crucial for the management of patients with portal hypertension, was the development of animal models. These allowed the full characterization of the profound hemodynamic abnormalities in the systemic and splanchnic circulation associated with portal hypertension, and the elucidation of the molecular mechanisms implicated in these disturbances. This review traces how seminal clinical observations in the 1950s raised meaningful questions that were subsequently answered at the bench, leading to our current understanding of the pathophysiology of portal hypertension and of the pathogenesis of severe complications of cirrhosis, such as variceal bleeding or ascites.
- 1 January 2004
- Published by Elsevier in Seminars in Hematology
- Vol. 41, 8-12
Management of gastrointestinal bleeding in patients with cirrhosis of the liver
- 1 January 2004
- Published by Elsevier in Seminars in Hematology
- Vol. 41, 8-12
Management of gastrointestinal bleeding in patients with cirrhosis of the liver
- 1 January 2003
- Published by Elsevier in Journal of Hepatology
- Vol. 38, 54-68
Current management of portal hypertension
- 1 January 2003
- Published by Elsevier in Journal of Hepatology
- Vol. 38, 54-68
Current management of portal hypertension
- 1 December 2002
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 17, S232-S241
Novel approaches to treat portal hypertension
- 1 December 2002
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 17, S232-S241
Novel approaches to treat portal hypertension
- 30 April 2002
- Published by Elsevier in Journal of Hepatology
- Vol. 36, 51
Hemodynamic effects of albumin administration in spontaneous bacterial peritonitis
- 30 April 2002
- Published by Elsevier in Journal of Hepatology
- Vol. 36, 51
Hemodynamic effects of albumin administration in spontaneous bacterial peritonitis